Performing robust exploratory tests upfront can save time and money later on in the process. This infographic outlines the top reasons for why clients are encouraged to consider a comprehensive exploratory toxicology program and how it can provide success in GLP studies.
Register to gain access to gated resources.
Thank you for registering!
You now have the option of downloading the resource or viewing the web version below.
Frontage Virtual Tour: Do a 3D walkthrough of our site at 760 Pennsylvania Dr, Exton, PA 19341. In 2021 we opened our new 71,000-square-foot laboratory facility in Exton, PA. This new location supports our Bioanalytical, CMC, and Central Lab businesses. Our Bioanalytical suites focus on large molecules, biomarkers, and genomics. Our CMC laboratories feature a large analytical automation lab for small and large molecules, microbiology, and cell-based assays. Our large central laboratory includes a dedicated histology and pathology suite.
Frontage develops a full validation of the XTMAB-16 NAb (neutralizing antibody) assay with acceptable drug and target tolerances to guide future clinical trials.
Sequencing the bacterial 16S rRNA gene is an established technique for assessing the phylogenetic diversity of microbial communities. This white paper discusses the methods and process to elucidate that Frontage’s QIIME2 analysis pipeline accurately estimates the composition of microbiome samples, as shown by the similarity to the theoretical abundance.